RIVER ROAD TMS
(TRANSCRANIAL MAGNETIC STIMULATION)
What is Transcranial Magnetic Stimulation (TMS)?
Transcranial Magnetic Stimulation, or TMS, is a safe, non-invasive treatment that uses gentle magnetic pulses to stimulate specific areas of the brain involved in mood regulation. By activating these regions, TMS can help improve communication between brain cells and relieve symptoms of depression and other mental health conditions.
Unlike medication, TMS does not involve drugs, require anesthesia, or cause lasting side effects. Treatments are done in-office and take less than thirty minutes. Over the course of therapy, many people experience significant improvement in their mood, energy, and overall quality of life.
At River Road TMS, we offer Neurostar Advanced TMS Therapy
What does this mean?
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
Learn more
about TMS
ABOUT
Discover our mission, values, and why we’re passionate about bringing hope and healing through TMS.
MEET THE CARE PROVIDERS
Get to know the experts who will guide you through your treatment journey.
FAQ
Have questions about how TMS works? Find clear answers to the most common ones here.
0%
Measurable
Improvement
A real-world study reported an 83% response rate. This means that 83% of patients that completed their NeuroStar treatment cycle saw measurable improvement in their depression symptoms.**[12]
0%
COMPLETE
REMISSION
The same real-world study reported a 62% remission rate. This means that 62% of patients that completed their NeuroStar treatment cycle likely wouldn’t be diagnosed with MDD if they were first being evaluated by their doctor.**[12]